Initial model | Final model | |||||
---|---|---|---|---|---|---|
B | p-value | R2 | B | p-value | R2 | |
SPADI at 8 weeks | 0.30 | 0.29 | ||||
SHC Pseudoneurology baseline | 2.4 | 0.001 | 2.6 | < 0.001 | ||
Gender (male = 0; female = 1) | 0.78 | 0.85 | ||||
Age | − 0.36 | 0.15 | ||||
Group allocation (control = 0; intervention = 1) | − 25.1 | < 0.001 | − 24.8 | < 0.001 | ||
Change in SPADI from baseline to 8 weeks | 0.36 | 0.36 | ||||
SHC Pseudoneurology baseline | 0.19 | 0.77 | ||||
Gender (male = 0; female = 1) | 11.78 | 0.002 | 11.99 | 0.002 | ||
Age | 0.48 | 0.04 | 0.47 | 0.04 | ||
Group allocation (control = 0; intervention = 1) | 19.50 | < 0.001 | 19.73 | < 0.001 | ||
Shoulder pain duration | 0.93 | 0.91 | 0.013 |